{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:52:18Z","timestamp":1791978738527,"version":"4.4.0"},"reference-count":2,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K08 DK123403"],"award-info":[{"award-number":["K08 DK123403"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1093\/ibd\/izag204","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:15:21Z","timestamp":1790334921000},"source":"Crossref","is-referenced-by-count":0,"title":["The right dose for the right patient: Toward precision infliximab therapy in acute severe ulcerative colitis"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5511-2099","authenticated-orcid":false,"given":"Manjeet K","family":"Goyal","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Human Nutrition Unit, All India Institute of Medical Sciences , New Delhi, Delhi, 110029,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4823-5805","authenticated-orcid":false,"given":"Shrinivas","family":"Bishu","sequence":"additional","affiliation":[{"name":"Divison of Gastroenterology and Hepatology, University of Michigan , Ann Arbor, MI 48109,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"key":"2026101407304419200_izag204-B1","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1093\/ibd\/izag042","article-title":"Rethinking the dose: a Bayesian meta-analysis of infliximab intensification in acute severe ulcerative colitis","volume":"32","author":"Goyal","year":"2026","journal-title":"Inflamm Bowel Dis"},{"key":"2026101407304419200_izag204-B2","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/S2468-1253(24)00200-0","article-title":"Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial","volume":"9","author":"Choy","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/advance-article-pdf\/doi\/10.1093\/ibd\/izag204\/71943204\/izag204.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/advance-article-pdf\/doi\/10.1093\/ibd\/izag204\/71943204\/izag204.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:30:47Z","timestamp":1791977447000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/advance-article\/doi\/10.1093\/ibd\/izag204\/8916308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,14]]},"references-count":2,"URL":"https:\/\/doi.org\/10.1093\/ibd\/izag204","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,14]]},"article-number":"izag204"}}